Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts

In this episode, John Mascarenhas, MD, and Ruben A. Mesa, MD, FACP, discuss current best practices and emerging approaches for treating patients with myelofibrosis, including:Overall approach to treatmentUse of JAK inhibitors for treating myelofibrosisTreating patients with low plateletsDefining JAK inhibitor failureUnmet needs in treatment and emerging therapeutic options, including momelotinib, luspatercept, ruxolitinib add-on therapy, and other phase III approachesPresenters: John Mascarenhas, MDProfessor of MedicineIcahn School of Medicine at Mount SinaiDirector, Adult Leukemia ProgramLeader, Myeloproliferative Disorders Clinical Research ProgramDivision of Hematology/OncologyTisch Cancer InstituteNew York, New York Ruben A. Mesa, MD, FACPExecutive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer CenterEnterprise Senior Vice President, Atrium HealthPresident, Enterprise Cancer Service LineVice Dean for Cancer Programs, Wake Forest University School of MedicineProfessor of Medicine, Wake Forest University School of Medicine Winston-Salem, North Carolina Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.